257 related articles for article (PubMed ID: 25858562)
1. GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese Mice.
Tomas E; Stanojevic V; McManus K; Khatri A; Everill P; Bachovchin WW; Habener JF
Diabetes; 2015 Jul; 64(7):2409-19. PubMed ID: 25858562
[TBL] [Abstract][Full Text] [Related]
2. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
Tomas E; Wood JA; Stanojevic V; Habener JF
Regul Pept; 2011 Aug; 169(1-3):43-8. PubMed ID: 21549160
[TBL] [Abstract][Full Text] [Related]
3. EGLP-1 lowers body weight better than exendin-4 by reducing food intake and increasing basal energy expenditure in diet-induced obese mice.
Gao H; Zhao Q; Li K; Qin F; Yin X; Lu Z; Song Z; Wu Y; Shen Y; Pan Y; Jin L; Yanfeng Zhang
Exp Cell Res; 2021 Feb; 399(1):112454. PubMed ID: 33359447
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1(9-36)amide metabolite inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
Tomas E; Wood JA; Stanojevic V; Habener JF
Diabetes Obes Metab; 2011 Jan; 13(1):26-33. PubMed ID: 21114600
[TBL] [Abstract][Full Text] [Related]
5. Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure.
Knauf C; Cani PD; Ait-Belgnaoui A; Benani A; Dray C; Cabou C; Colom A; Uldry M; Rastrelli S; Sabatier E; Godet N; Waget A; Pénicaud L; Valet P; Burcelin R
Endocrinology; 2008 Oct; 149(10):4768-77. PubMed ID: 18556349
[TBL] [Abstract][Full Text] [Related]
6. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
[TBL] [Abstract][Full Text] [Related]
7. Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats.
Alemzadeh R; Karlstad MD; Tushaus K; Buchholz M
Metabolism; 2008 Nov; 57(11):1597-607. PubMed ID: 18940400
[TBL] [Abstract][Full Text] [Related]
8. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK.
Beiroa D; Imbernon M; Gallego R; Senra A; Herranz D; Villarroya F; Serrano M; Fernø J; Salvador J; Escalada J; Dieguez C; Lopez M; Frühbeck G; Nogueiras R
Diabetes; 2014 Oct; 63(10):3346-58. PubMed ID: 24917578
[TBL] [Abstract][Full Text] [Related]
9. GLP-1-derived nonapeptide GLP-1(28-36)amide represses hepatic gluconeogenic gene expression and improves pyruvate tolerance in high-fat diet-fed mice.
Ip W; Shao W; Chiang YT; Jin T
Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1348-58. PubMed ID: 24085036
[TBL] [Abstract][Full Text] [Related]
10. Contribution of brown adipose tissue activity to the control of energy balance by GLP-1 receptor signalling in mice.
Heppner KM; Marks S; Holland J; Ottaway N; Smiley D; Dimarchi R; Perez-Tilve D
Diabetologia; 2015 Sep; 58(9):2124-32. PubMed ID: 26049402
[TBL] [Abstract][Full Text] [Related]
11. GLP-1-derived nonapeptide GLP-1(28-36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes.
Tomas E; Stanojevic V; Habener JF
Regul Pept; 2011 Apr; 167(2-3):177-84. PubMed ID: 21256872
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide improves insulin sensitivity in high fat diet induced diabetic mice through multiple pathways.
Zhou JY; Poudel A; Welchko R; Mekala N; Chandramani-Shivalingappa P; Rosca MG; Li L
Eur J Pharmacol; 2019 Oct; 861():172594. PubMed ID: 31412267
[TBL] [Abstract][Full Text] [Related]
13. The novel dipeptidyl peptidase-4 inhibitor teneligliptin prevents high-fat diet-induced obesity accompanied with increased energy expenditure in mice.
Fukuda-Tsuru S; Kakimoto T; Utsumi H; Kiuchi S; Ishii S
Eur J Pharmacol; 2014 Jan; 723():207-15. PubMed ID: 24309217
[TBL] [Abstract][Full Text] [Related]
14. Supplemental epilactose prevents metabolic disorders through uncoupling protein-1 induction in the skeletal muscle of mice fed high-fat diets.
Murakami Y; Ojima-Kato T; Saburi W; Mori H; Matsui H; Tanabe S; Suzuki T
Br J Nutr; 2015 Dec; 114(11):1774-83. PubMed ID: 26395755
[TBL] [Abstract][Full Text] [Related]
15. BDNF mimetic alleviates body weight gain in obese mice by enhancing mitochondrial biogenesis in skeletal muscle.
Wood J; Tse MCL; Yang X; Brobst D; Liu Z; Pang BPS; Chan WS; Zaw AM; Chow BKC; Ye K; Lee CW; Chan CB
Metabolism; 2018 Oct; 87():113-122. PubMed ID: 29935237
[TBL] [Abstract][Full Text] [Related]
16. Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors.
Vijayakumar RS; Lin Y; Shia KS; Yeh YN; Hsieh WP; Hsiao WC; Chang CP; Chao YS; Hung MS
Int J Obes (Lond); 2012 Jul; 36(7):999-1006. PubMed ID: 21894162
[TBL] [Abstract][Full Text] [Related]
17. Exendin-4 increases oxygen consumption and thermogenic gene expression in muscle cells.
Choung JS; Lee YS; Jun HS
J Mol Endocrinol; 2017 Feb; 58(2):79-90. PubMed ID: 27872157
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological targeting of glucagon and glucagon-like peptide 1 receptors has different effects on energy state and glucose homeostasis in diet-induced obese mice.
Gu W; Lloyd DJ; Chinookswong N; Komorowski R; Sivits G; Graham M; Winters KA; Yan H; Boros LG; Lindberg RA; Véniant MM
J Pharmacol Exp Ther; 2011 Jul; 338(1):70-81. PubMed ID: 21471191
[TBL] [Abstract][Full Text] [Related]
19. Exendin-4 improves thermogenic capacity by regulating fat metabolism on brown adipose tissue in mice with diet-induced obesity.
Wei Q; Li L; Chen JA; Wang SH; Sun ZL
Ann Clin Lab Sci; 2015; 45(2):158-65. PubMed ID: 25887869
[TBL] [Abstract][Full Text] [Related]
20. Combination of Lorcaserin and GLP-1/glucagon Coagonist Improves Metabolic Dysfunction in Diet Induced-obese Mice.
Patel V; Joharapurkar A; Kshirsagar S; Patel M; Savsani H; Bahekar R; Jain M
Drug Res (Stuttg); 2020 Aug; 70(8):376-384. PubMed ID: 32645724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
